BrainsWay Ltd. (BWAY) is a Medical - Devices company in the Healthcare sector, currently trading at $15.81. It has a SharesGrow Score of 68/100, indicating a above average investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of BWAY = $14.70 (-7% from the current price, the stock appears fairly valued). Analyst consensus target is BWAY = $30 (+89.8% upside).
Valuation: BWAY trades at a trailing Price-to-Earnings (P/E) of 63.4 (S&P 500 average ~25).
Financials: revenue is $53M, +24.8%/yr average growth. Net income is $8M, growing at +133.8%/yr. Net profit margin is 14.6% (healthy). Gross margin is 75.4% (+1.6 pp trend).
Balance sheet: total debt is $7M against $73M equity (Debt-to-Equity (D/E) ratio 0.09, conservative). Current ratio is 3.83 (strong liquidity). Debt-to-assets is 6%. Total assets: $113M.
Analyst outlook: 5 / 6 analysts rate BWAY as buy (83%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 58/100 (Partial), Growth 100/100 (Pass), Past 50/100 (Partial), Health 67/100 (Partial), Moat 52/100 (Partial), Future 94/100 (Pass), Income 55/100 (Partial).
